引用次数
引用: 2,099
H-指数: 28
I10-指数 : 38
出版物: 65
Bone morphogenetic proteins and MYC in multiple myeloma
Toril Holien
Norges teknisk-naturvitenskapelige universitet, Det medisinske fakultet, Institutt for kreftforskning og molekylær medisin
2012
Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells
Unn-Merete Fagerli , Thorsten Stühmer , Toril Holien , Randi Utne Holt
Blood 116 ( 21) 1915 -1915
2010
TGF-β contamination of purified recombinant GDF15.
Oddrun Elise Olsen , Anette Skjærvik , Berit Fladvad Størdal , Anders Sundan
PLOS ONE 12 ( 11)
28
2017
MYC amplifications in myeloma cell lines; correlation with MYC-inhibitor efficacy
Toril Holien , Kristine Misund , Oddrun Elise Olsen , Katarzyna Anna Baranowska
Oncotarget 6 ( 26) 22698 -22705
13
2015
Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
Huabo Wang , Peter Teriete , Angela Hu , Dhanya Raveendra-Panickar
Oncotarget 6 ( 32) 32380 -32395
31
2015
Oncogene addiction to c-MYC in myeloma cells.
Toril Holien , Anders Sundan
Oncotarget 3 ( 8) 739 -740
23
2012
Monitoring multiple myeloma by quantification of recurrent mutations in serum.
Even Holth Rustad , Eivind Coward , Emilie R Skytøen , Kristine Misund
Haematologica 102 ( 7) 1266 -1272
31
2017
Addiction to c-MYC in multiple myeloma
Toril Holien , Thea Kristin Våtsveen , Hanne Hella , Anders Waage
Blood 120 ( 12) 2450 -2453
111
2012
Src Family Kinases are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3
Pegah Abdollahi , Esten N. Vandsemb , Magnus A. Hjort , Kristine Misund
Molecular Cancer Research 15 ( 1) 69 -77
10
2017
Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.
Toril Holien , Oddrun E. Olsen , Kristine Misund , Hanne Hella
European Journal of Haematology 91 ( 4) 339 -346
27
2013
GDF15 Promotes Osteoclast Differentiation and High Serum GDF15 Levels Are Associated with Multiple Myeloma Bone Disease
Marita Westhrin , Siv Helen Moen , Toril Holien , Oddrun Elise Olsen
Blood 124 ( 21) 2065 -2065
2014
Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells
Katarzyna Baranowska , Kristine Misund , Kristian K. Starheim , Toril Holien
Oncotarget 7 ( 43) 70845 -70856
19
2016
Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis.
Sagar Darvekar , Petras Juzenas , Morten Oksvold , Andrius Kleinauskas
Cancers 12 ( 2) 377
4
2020
The role of bone morphogenetic proteins in myeloma cell survival
Toril Holien , Anders Sundan
Cytokine & Growth Factor Reviews 25 ( 3) 343 -350
15
2014
Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Agaricus blazei Murill Based Mushroom Extract, Andosan™.
Jon-Magnus Tangen , Toril Holien , Mohammad Reza Mirlashari , Kristine Misund
BioMed Research International 2017 2059825
3
2017
VOLIN and KJON-Two novel hyperdiploid myeloma cell lines.
Thea Kristin Våtsveen , Magne Børset , Aida Dikic , Erming Tian
Genes, Chromosomes and Cancer 55 ( 11) 890 -901
6
2016
HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase.
Torstein Baade Rø , Toril Holien , Unn-Merete Fagerli , Håkon Hov
Experimental Hematology 41 ( 7) 646 -655
17
2013
BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
Oddrun Elise Olsen , Meenu Sankar , Samah Elsaadi , Hanne Hella
Journal of Cell Science 131 ( 11)
24
2018
A Method for Measurement of Drug Sensitivity of Myeloma Cells Co-Cultured with Bone Marrow Stromal Cells
Kristine Misund , Katarzyna Anna Baranowska , Toril Holien , Christoph Rampa
Blood 120 ( 21) 1373 -1373
3
2012
The proportion of CD16+CD14dim monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma
Anne M. Sponaas , Siv H. Moen , Nina B. Liabakk , Emadoldin Feyzi
Immunity, inflammation and disease 3 ( 2) 94 -102
15
2015